VivoSeq
Other

Alcohol Drinking

24

Pipeline Programs↗

9

Active Trials↗

16

Companies Involved↗

Alcohol Drinking is an emerging landscape with 24 programs across 16 companies. The most active players are Taisho Pharmaceutical Co., Ltd., Teva, Astellas. 9 therapies are approved with 1 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

51/100

Pipeline Velocity

22/100

Mech. Concentration

6/100

Completion Rate

92/100

Attrition Rate

5/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

T

Taisho Pharmaceutical Co., Ltd.

1 program

Phase 1Teva logo

Teva

1 program

Phase 1Astellas logo

Astellas

1 program

Phase 2Sanofi logo

Sanofi

1 program

Phase 2C

Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

1 program

Phase 2A

Azurity Pharmaceuticals

1 program

Phase 2

Pipeline

Programs by Phase

Analysis

Trial Status

22

clinical trials

Completed12 · 55%
Recruiting5 · 23%
Not yet recruiting2 · 9%
Withdrawn1 · 5%
Active, not recruiting1 · 5%
Enrolling by invitation1 · 5%

Clinical Trials

Trial Activity

22 trials

Nicotinic Receptor Genetic Variation and Alcohol Reward
Recruiting·National Institute on Alcohol Abuse and Alcoholism (NIAAA)·Phase 1·NCT03294460·128 enrolled
Feasibility and Preliminary Efficacy of a 30-Day Reset Challenge
Recruiting·UUniversity of Oklahoma·Preclinical·NCT07591428·150 enrolled
Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study
Recruiting·IIcahn School of Medicine at Mount Sinai·Preclinical·NCT05675332·280 enrolled
COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study
Recruiting·National Institute on Alcohol Abuse and Alcoholism (NIAAA)·N/A·NCT04391816·1,500 enrolled
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
Recruiting·BBrown University·Preclinical·NCT07663448·30 enrolled
Digital Motivational Behavioral Economic Intervention to Reduce Risky Drinking Among Community-Dwelling Emerging Adults
Active, not recruiting·UUniversity of Florida·Preclinical·NCT05443750·806 enrolled
Pilot Study: Effects of Nimodipine on Alcohol Drinking
Not yet recruiting·YYale University·Phase 2·NCT06900998·5 enrolled
Developing and Testing an Online Intervention for Decreasing Alcohol and Cannabis Misuse and Increasing Healthy Relationship Skills Among Young Adult Couples: A Comprehensive Mixed-methods Approach
Not yet recruiting·UUniversity of Washington·Preclinical·NCT06422299·60 enrolled
Successive Cohort Design to Iteratively Develop mSTARS
Enrolling by invitation·DDuke University·Preclinical·NCT05847504·10 enrolled
A Study on the Biobehavioral Mechanisms of Baclofen and Alcohol Drinking
Completed·—·Phase 2·NCT01076283·14 enrolled
Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors
Completed·YYale University·Phase 1·NCT01625611·59 enrolled
Saracatinib and Alcohol Drinking
Completed·YYale University·Phase 2·NCT02955186·50 enrolled
Puerarin Effects on Alcohol Drinking
Completed·MMclean Hospital·Phase 2·NCT00854724·16 enrolled
Mavoglurant in Alcohol Drinking
Completed·YYale University·Phase 1·NCT03327792·34 enrolled
Aripiprazole Effects on Alcohol Drinking and Craving
Completed·MMedical University of South Carolina·Phase 3·NCT01292057·99 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)